Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash $ 8,658,031 $ 9,601,298
Prepaid expenses and other current assets 1,043,825 473,834
Australia research and development incentives receivable 77,347
Total current assets 9,701,856 10,152,479
Other assets 2,800 2,800
Total assets 9,704,656 10,155,279
Current liabilities:    
Accounts payable 2,038,803 1,512,436
Accrued expenses 3,797,595 2,317,602
Total current liabilities 5,836,398 3,830,038
Long term liabilities:    
Warrant liability 1,492,395 2,690,605
Total liabilities 7,328,793 6,520,643
Commitments and contingencies (Note 7)
Stockholders’ equity (deficit)    
Preferred stock, 0.0001 par value, 30,000,000 shares authorized at December 31, 2025 and December 31, 2024, 0 shares issued and outstanding
Common stock, $0.0001 par value, 150,000,000 and 70,000,000 shares authorized at December 31, 2025 and December 31, 2024, 38,624,289 and 26,157,788 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively 3,863 2,616
Additional paid-in capital 112,053,233 90,897,468
Accumulated deficit (109,631,005) (87,234,833)
Accumulated other comprehensive loss (50,228) (30,615)
Total stockholders’ equity 2,375,863 3,634,636
Total liabilities and stockholders’ equity $ 9,704,656 $ 10,155,279